Introduction {#h0.0}
============

*Staphylococcus aureus* is a highly significant pathogen causing multiple types of infections in both the community and the nosocomial environment. Infections caused by this bacterium range from minor pustules and skin and soft tissue infections to biofilm-mediated infections, necrotizing pneumonia, endocarditis, and osteomyelitis. Central to the pathogenicity of *S. aureus* is the synthesis of many coordinately regulated virulence factors, including superantigens, adherence factors, pore-forming toxins, and immunological mediators ([@B1]). We are just beginning to understand the significance of interactions between virulence factors and their relationship to specific types of infections. For example, utilizing a mouse sepsis model, Cheng and colleagues demonstrated that early-phase dissemination of *S. aureus* is ClfA and ClfB dependent but that IsdA, IsdB, Spa, and SdrD are required for kidney abscess formation ([@B2]), suggesting that unique factors are required at distinct stages in the pathogenesis process. Furthermore, factors responsible for foreign-body-mediated biofilm infections are clearly distinct from those responsible for disseminated disease ([@B3]). Additional detailed studies are required to fully understand the specific metabolic genes or virulence factors that are required for specific types of infection to promote the development of novel therapeutic modalities, including vaccines.

To support studies aimed at understanding the pathogenesis, colonization, and biology of *S. aureus*, we developed a sequence-defined *bursa aurealis* ([@B4]) transposon (Tn) library in *S. aureus* USA300 ([@B5]) JE2 called the Nebraska Transposon Mutant Library (NTML), which is deposited in the Network on Antimicrobial Resistance in *Staphylococcus aureus* (NARSA) strain repository. *bursa aurealis* is a *mariner*-based transposon ([@B6], [@B7]) that has previously been shown to generate random transposon mutations in *S. aureus* ([@B4]). The USA300 (ST8) JE2 genetic background was utilized as a host for the NTML due to its decade-long stability as the most prominent community-associated methicillin-resistant *S. aureus* (CA-MRSA) lineage in the United States and because its genome sequence is known ([@B5], [@B8]). The NTML will provide investigators with a tool to address specific hypotheses rapidly without undergoing the time-constraining process of creating specific-allelic-replacement mutations. Currently, 1,952 specific *bursa aurealis* mutants of the USA300 strain JE2 have been deposited in the NARSA strain repository, available to all registered investigators (<http://www.narsa.net>).

RESULTS AND DISCUSSION {#h1}
======================

Generation of the Nebraska Transposon Mutant Library. {#h1.1}
-----------------------------------------------------

The *S. aureus* USA300 FPR3757 chromosomal genome sequence (GenBank accession number [NC_007793.1](NC_007793.1)) was used to map transpositions of *bursa aurealis* from the delivery plasmid pBursa into the genome of *S. aureus* JE2 (see [Fig. S1](#figS1){ref-type="supplementary-material"} and [S2](#figS2){ref-type="supplementary-material"} in the supplemental material). The Nebraska Transposon Mutant Library (NTML) is a carefully selected subset of 1,952 protein coding sequences (CDS) disrupted by *bursa aurealis* Tn insertion mutant clones from a larger set of 18,797 Tn insertion clones from which mappable DNA sequencing reads were obtained. The NTML provides the research community with a comprehensive set of Tn insertion mutant clones at sites throughout the JE2 chromosome, with the distribution of hits unbiased by Tn insertion orientation or the length of the AciI-bounded fragments (range, 3 to 8,709 bp; median, 425 bp; interquartile range, 146 to 923 bp) from which pBursa-derived Tn insertions are characterized ([Fig. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}; see also [Fig. S3](#figS3){ref-type="supplementary-material"}). The average BLASTn alignment obtained when mapping Tn insertion clone-derived Sanger DNA sequencing reads against the FPR3757 genome (which differs from the JE2 genome at only 11 single nucleotide polymorphisms \[SNPs\] \[[@B8]\]) was 448 bp long (standard deviation = 284 bp), with an expected value of 1e−135 and a percent identity of 97% (see [Fig. S2](#figS2){ref-type="supplementary-material"}). The cumulative sequencing progress shown in [Fig. S4](#figS4){ref-type="supplementary-material"} and [S5](#figS5){ref-type="supplementary-material"} indicates that additional sequencing beyond the 18,797 Tn insertion clones sequenced to date is unlikely to increase the number of distinct chromosomal CDS gene hits substantially.

![Distribution of Nebraska Transposon Mutant Library Transposon insertion sites in the *S. aureus* USA300 LAC JE2 genome.](mbo0011314460001){#fig1}

![GView visualization of the mapping of *bursa aurealis* transposon insertion mutants of the Nebraska Transposon Mutant Library (NTML). GView (44) software was used to visualize the entire NTML using a custom GView style sheet and a version of the *S. aureus* USA300 FPR3757 RefSeq genome GenBank sequence (accession number [NC_007793.1](NC_007793.1)). The map's backbone (central solid black line) distinguishes the given (positive) strand of the GenBank sequence (shown outside the backbone) from the reverse complement strand (shown inside the backbone). Tn insertions (red arrowheads, closest to the backbone and so dense that they often merge at the resolution shown) and CDS genes for which Tn insertion mutants were not obtained (green arrowheads, furthest from the backbone) are also shown on either strand. Annotated GenBank genes are shown as arrowheads (gold or silver on either strand, as indicated).](mbo0011314460002){#fig2}

[Table 1](#tab1){ref-type="table"} provides an overview of the annotated features in the RefSeq DNA sequence for the USA300 FPR3757 chromosomal genome. The 1,952 NTML clones all disrupt the CDS, whereas 27% of the 16,845 "extra" Tn insertion mutations map to the 16% of the chromosomal genome that is intergenic ([Tables 1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}). Over two-thirds (68%) of the NTML Tn mutant clones were selected because of the presence of Tn insertions in the first third of the length of the affected gene. Another 24% of the clones contained Tn insertions between the first one-third and two-thirds of the affected genes' lengths, and only 7% of the mutant clones had insertions beyond two-thirds of the affected gene. No mutant clones with insertions beyond 90% of the genes' lengths were included in the NTML. Thus, it is predicted that the function of each gene/protein will be lost due to the insertion of the transposon in each NTML mutant, maximizing the utility of the library for functional genomic analyses.

###### 

GenBank RefSeq feature table entries for the USA300 FPR3757 genome^[*a*](#ngtab1.1)^

  -----------------------------------------------------------------------------------------------
  *Staphylococcus aureus* subsp. *aureus* USA300\   Count   \%       No. of bp (total)   \%
  FPR3757 GenBank RefSeq feature                                                         
  ------------------------------------------------- ------- -------- ------------------- --------
  Entire genome                                                      2,872,769           100.00

  All genes                                         2,648   100.00   2,408,457           83.84

  CDS genes                                         2,560   96.68    2,359,416           82.13

  rRNA genes                                        16      0.60     23,080              0.80

  tRNA genes                                        53      2.00     4,099               0.14

  Pseudogenes                                       18      0.68     21,503              0.75

  Other genes, including *ssrA* (SAUSA300_0766;\    1       0.04     359                 0.01
  10Sa RNA→tmRNA)                                                                        

  Intergenic sequences                                               464,312             16.16

  Nongene features (SCC*mecIV*, *ACME*, *vSAα*,\    7                224,465             7.81
  *SaPI5*, *ϕSA2USA*, *vSAβ*, *ϕSA3USA*)                                                 
  -----------------------------------------------------------------------------------------------

tmRNA, transfer-messenger RNA; SCC*mecIV*, staphylococcal cassette *mec* chromosome IV.

###### 

Summary of NTML and extra Tn insertion mutants in the *S. aureus* USA300 LAC JE2 genome, based on mapping software results using the USA300 FPR3757 GenBank genome

  Type of insertion                                  NTML clones   Extra insertion mutants            
  -------------------------------------------------- ------------- ------------------------- -------- -----
  Transposon insertions between and within genes                                                      
  All insertions                                     1,952         100                       16,845   100
  Insertions between genes                           0             0                         4,632    27
  Insertions affecting ≥1 gene^[*a*](#ngtab2.1)^     1,956         100                       12,228   73
  Insertions affecting 2 genes^[*a*](#ngtab2.1)^     4                                       15       
  Insertions affecting \>2 genes^[*a*](#ngtab2.1)^   0                                       0        
  Transposon insertions within CDS genes                                                              
  All insertions                                     1,954         100                       12,034   100
      Within the first third of gene length          1,336         68                        3,889    32
      Within the second third of gene length         472           24                        3,934    33
      Within the last third of gene length           146           7                         4,211    35
  Distinct CDS genes                                 2,560         100                       2,560    100
  Distinct CDS with 0 insertions                     615           24                        661      26
  Distinct CDS with ≥1 insertion                     1,945         76                        1,899    74
      Within the first third of gene length          1,332                                   1,194    
      Within the second third of gene length         472                                     1,336    
      Within the last third of gene length           146                                     1,456    

Gene = CDS, rRNA, tRNA, pseudogene, or other gene.

Phenotypic analysis of the Nebraska Transposon Mutant Library. {#h1.2}
--------------------------------------------------------------

To demonstrate the utility of the NTML in the identification of genes involved in various processes important to *S. aureus* pathogenesis and metabolism, we screened all 1,952 mutants in agar plate assays for hemolysin production, protease activity, carotenoid pigment formation, and mannitol fermentation (see [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material). It is important to note that we did not perform studies to assess the possibility of polar effects. However, many of the mutants exhibiting phenotypes described below have Tn insertion phenotypes that stand alone and are not associated with other upstream or downstream Tn insertions that produced the same phenotypes, suggesting the absence of polar effects. Regardless, the phenotype associated with each mutant in the library must be confirmed using standard genetic techniques, including phage backcross, complementation, and possibly specific allelic replacement.

Hemolysis. {#h1.3}
----------

To assess the impact of mutations on α-hemolysin production, we spotted each mutant onto rabbit blood agar medium and examined the sizes of the zones of hemolysis produced by each strain. The observed hemolytic activity was found to be dependent solely on α-hemolysin, since the insertion in *hla* (SAUSA300_1058) was completely nonhemolytic and none of the other hemolysin mutants exhibited altered hemolytic activity in this assay. As shown in [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material, we identified 71 mutants that exhibited alterations in the amount of α-hemolysin produced. Sixty-four of these demonstrated reduced hemolysin production, while seven exhibited increased production. As expected, mutations in *hla*, *agr* (*agrA*, *agrB*, and *agrC*), and *saeR* resulted in reduced hemolysis ([@B9], [@B10]), while σ^B^ (*rsbU*, *rsbV*, *rsbW*, and *rpoF*) and *codY* mutations caused increased hemolysis ([@B11], [@B12]). Interestingly, we also identified several genes encoding metabolic enzymes, including *ureF* (encoding urease accessory protein), *moeA* (encoding molybdopterin biosynthesis protein A), *brnQ* (encoding branched-chain amino acid transport system II carrier protein), *fba* (encoding fructose bisphosphate aldolase), and *sucC* (encoding succinyl-coenzyme A \[CoA\] synthetase). Interestingly, the *ureF* gene is part of a large operon yet is the only gene of this operon whose disruption produces this phenotype. Besides CodY and the σ^B^ system, only two other mutant proteins resulted in increased hemolytic activity, SAUSA300_2026 and SAUSA300_0014, a PemK family and a DHH subfamily phosphodiesterase, respectively. We did not, however, identify altered hemolytic activity during this screen of mutants containing Tn insertions within several known regulators of α-hemolysin, including SarA ([@B13]), SarT ([@B14]), Rot ([@B15]), and ArlSR ([@B16]), likely due to the well-documented strain-dependent regulation of the *hla* gene ([@B13]). Interestingly, we found that an insertion into the gene encoding Stk1 (also called PknB) had decreased activity but that a previous mutant of strain Newman had the opposite phenotype ([@B17]).

Protease activity. {#h1.4}
------------------

Protease activity produced by *S. aureus* has also been a widely studied trait with a variety of known roles in pathogenesis ([@B18], [@B19]). Although *S. aureus* produces an abundance of different proteases, casein agar plates were used to assess genes that function specifically in the hydrolysis of casein. As shown in [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material, 62 mutants exhibited differences in protease activity in this assay. Fifty produced lower levels of protease activity, while 12 produced higher levels. Of those that produced lower protease levels, only two contained genes that encoded known secreted proteases, *scpA* (encoding staphopain A) and *aur* (encoding aureolysin). Tn insertions within other secreted-protease genes within the USA300 genome, including the *spl* operon (encoding serine proteases) and the V8 protease gene *sspA*, did not result in altered protease activity in comparison to that in JE2. Interestingly, 12 known regulators were also found to affect protease production. Six of these, *agrA*, *agrB*, *agrC*, *ccpA*, *purR*, and *clpP*, caused decreased protease activity consistent with previous reports ([@B20]--[@B22]), while six, *sarA*, *rsbU*, *rsbV*, *rsbW*, *rpoF*, and *saeR*, caused increased protease levels, as previously observed ([@B23], [@B24]). By far the most common class of genes found to affect protease production consisted of those encoding metabolic enzymes ([Table S1](#tabS1){ref-type="supplementary-material"}), possibly reflecting the role of proteases in adapting to changing physiological conditions.

Pigment formation. {#h1.5}
------------------

The well-recognized carotenoid pigment staphyloxanthin produced by *S. aureus* has been shown to be a key pathogenic factor important in the resistance of the bacteria to the oxidative burst elicited upon engulfment by immune cells ([@B25], [@B26]). The biosynthetic pathway leading to staphyloxanthin has been characterized, and the associated genes have been identified ([@B27], [@B28]). There are five genes in the *crt* operon (*crtO*, *crtP*, *crtQ*, *crtM*, and *crtN*) encoding the staphyloxanthin biosynthesis enzymes, all of which were found to eliminate pigment production ([Fig. 3](#fig3){ref-type="fig"}). Other mutants defective in earlier enzymes in this pathway also showed differences in pigment production. For example, the SAUSA300_1470 gene, encoding geranyltranstransferase, is involved in the biosynthesis of farnesyl diphosphate, an important precursor for carotenoid pigment and heptaprenyl diphosphate biosynthesis. Interestingly, a mutation affecting SAUSA300_1359, encoding polyprenyl synthetase, which converts farnesyl diphosphate to heptaprenyl diphosphate, results in dramatically increased carotenoid pigment production, suggesting that blocking this pathway provides more precursor for carotenoid pigment biosynthesis. In total, mutations in 38 genes, including *sarA*, *agr* (*agrA*, *agrB*, *agrC*), σ^B^ (*rsbU*, *rsbV*, *rsbW*, *rpoF*) ([@B29]), *purA*, *purB*, *clpP*, and *argR*, resulted in the loss of pigment production (see [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material).

![Staphyloxanthin biosynthesis. White arrows denote mutants with loss of pigmentation, and the black arrow denotes a mutant with increased pigmentations. Numbers in parentheses refer to the SAUSA300 ORF numbers encoding these proteins. PP, pyrophosphate.](mbo0011314460003){#fig3}

Mannitol utilization. {#h1.6}
---------------------

We also tested the library for mutants defective in fundamental physiological functions, such as carbohydrate metabolism. Given the importance of mannitol fermentation as a diagnostic indicator and the ease of testing for this in a plate assay, we screened the library on mannitol agar media, which assesses mannitol utilization as a function of the acids produced in agar medium in which mannitol is used as the sole carbohydrate source. Following transport via a phosphoenolpyruvate (PEP)-dependent phosphotransferase system (PTS) system, mannitol-1-phosphate is converted to fructose-6-phosphate by mannitol-1-phosphate 5-dehydrogenase and ultimately to pyruvate through the activity of pyruvate kinase. Only 7 of the 1,952 mutants in the library revealed differences in mannitol utilization ([Fig. 4](#fig4){ref-type="fig"}). One of the mutations resulting in an inability to utilize mannitol was in SAUSA300_0984 (*ptsI*), annotated as encoding PEP phosphotransferase, which is involved in carbohydrate transport and the conversion of PEP into pyruvate. A second mutation was in SAUSA300_1644 (*pyk*), which encodes pyruvate kinase, the enzyme that converts PEP to pyruvate. The five additional mutations identified during the screen were all found in the *mtl* operon ([Fig. 4](#fig4){ref-type="fig"}). Two of these mutants, NE929 (*mtlA*) and NE1737 (*mtlF*), contained insertions within the two components of the mannitol-specific PTS system ([@B30]). The two remaining transposon insertions were located in the *mtl* gene cluster: a putative transcriptional regulator (SAUSA300_2106) and mannitol-1-phosphate 5-dehydrogenase (SAUSA300_2108). The paucity of genes involved in mannitol utilization not only suggests that relatively few genes function to control mannitol catabolism but also demonstrates the utility of the NTML in identifying genes resulting in rare phenotypes.

![Mutants unable to utilize mannitol. Numbers below arrows are the SAUSA300 ORF numbers. Inverted triangles indicate locations of transposon insertions. All arrows are to scale. The NTML does not have mutants of 1645 or 0983. NE\# is the identifying number for the corresponding strains in the NTML; NA, not applicable.](mbo0011314460004){#fig4}

Essential genes. {#h1.7}
----------------

Several previous studies have addressed gene essentiality in *S. aureus* ([@B31]--[@B33]). In particular, Chaudhuri et al. recently utilized a transposon-mediated differential hybridization approach to identify 351 essential genes in *S. aureus* NCTC 8325 ([@B33]). As shown in [Table S2](#tabS2){ref-type="supplementary-material"} in the supplemental material, excluding the rRNA and tRNA genes, 579 open reading frames (ORFs) were not interrupted by a transposon in JE2 and may potentially be considered essential; however, these data clearly need to be confirmed using further gene essentiality studies. Two hundred ninety-two of 351 (83.2%) essential genes as identified by Chaudhuri et al. were also potentially essential in JE2. Of the 59 remaining essential genes in NCTC 8325, where a Tn insertion was identified in JE2, 23 (39.0%) had the Tn insertion in ≥90% of the total ORF length, suggesting the synthesis of a functional protein with the transposon inserted into the ORF ([Table S3](#tabS3){ref-type="supplementary-material"}). Of the remaining 287 genes not interrupted in JE2 ([Table S2](#tabS2){ref-type="supplementary-material"}), many are not predicted to be essential or are very small ORFs, suggesting that certain areas of the chromosome may not be amenable to *bursa aurealis* insertion and/or may have incomplete Tn saturation. However, it is possible that specific, unique genes are essential in JE2 under the growth conditions used in this assay. Supporting this hypothesis, 15/287 additional essential genes in JE2 ([Table S2](#tabS2){ref-type="supplementary-material"}) are considered essential in *B. subtilis* ([@B33]) but not in NCTC 8325.

In conclusion, we have generated a sequence-defined Tn mutant library with *S. aureus* USA300 JE2, from which registered NARSA users can rapidly acquire at no cost mutants of interest to further the study of this bacterium. To assist in the analysis of this resource, we have also developed a website (<http://app1.unmc.edu/fgx/>) that provides an interactive and user-friendly tool for the evaluation of the mutants available in this collection. The phenotypic screens performed in this study strongly suggest that the library is robust and carries the potential to uncover novel, previously unidentified, gene functions. Furthermore, to enhance the usefulness of the library, specific genetic tools have been developed to rapidly replace the erythromycin (Erm) resistance cassette within *bursa aurealis* with a *tetM* (tetracycline \[Tet\]/minocycline resistance), *aphA-3* (kanamycin resistance), or *aad9* (spectinomycin resistance) cassette ([@B34]). Other tools allow for transcriptional fusions with codon-optimized enhanced cyan fluorescent protein (ECFP), enhanced yellow fluorescent protein (EYFP), DsRed.T3(DNT), superfolder green fluorescent protein (sGFP), or eqFP650 ([@B34]). Overall, the availability of this unique combination of resources should greatly enhance the genetic analysis of this important pathogen.

MATERIALS AND METHODS {#h2}
=====================

Bacterial strains and growth conditions. {#h2.1}
----------------------------------------

The *Staphylococcus aureus* strains used in this study were derived from a USA300 strain isolated from a skin and soft tissue infection in a detainee from the Los Angeles County Jail (LAC) ([@B35]). *S. aureus* strain LAC contains two plasmids, p01 (a 3.1-kb cryptic plasmid) and p03 (a 27-kb plasmid conferring resistance to erythromycin) ([@B36]). Both p01 and p03 were removed from LAC for two reasons. First, curing of these two plasmids eliminated potential plasmid incompatibility concerns with pFA545 and pBursa (see below), and second, curing ensured that the *bursa aurealis* transposon did not insert preferentially into plasmid DNA. For removal of p03, strain LAC was grown overnight in Tryptic soy broth (TSB) with shaking at 37°C without antibiotics. The next day, serial dilutions were made and the cells were plated on Trypic soy agar (TSA) plates without any antibiotics. Colonies arising after overnight incubation at 37°C were then replica plated onto plates with and without erythromycin (5 µg/ml). Those colonies unable to grow on erythromycin were chosen, and the loss of the plasmid was confirmed by performing plasmid analysis (Promega, Madison, WI). After confirmation that no major genomic rearrangements had occurred by pulsed-field gel electrophoresis (PFGE) ([@B37]), one colony, designated LAC-13C, was selected for subsequent manipulation.

We next cured p01 from LAC-13C utilizing a plasmid incompatibility strategy. First, a chimeric plasmid in which pCL84 (conferring tetracycline resistance) ([@B38]) and p01 were ligated together at their unique EcoRI sites was created. This plasmid, designated pJE06, was then electroporated into *Escherichia coli* DH5α, purified, and subsequently electroporated into *S. aureus* RN4220 ([@B39]). pJE06 was then transduced from RN4220 using bacteriophage ϕ11 ([@B40]) into LAC-13C using methods as described by McNamara ([@B41]). Plasmid preparations of the resulting tetracycline-resistant transductants were screened for the loss of p01 due to plasmid incompatibility ([@B42]). The resulting strains were then cured of pJE06 by following the process described above for removal of pUSA03 except that the colonies were screened for tetracycline sensitivity. Multiple tetracycline-susceptible derivatives were examined by PFGE to ensure that no chromosomal rearrangements were detected; one strain was selected for subsequent use and designated JE2.

Transposon mutagenesis. {#h2.2}
-----------------------

The *mariner*-based transposon (Tn) *bursa aurealis* was used to generate random Tn insertion mutations in *S. aureus* strain JE2 essentially as described by Bae et al. ([@B4], [@B43]). First, bacteriophage ϕ11 was used to transduce the *bursa aurealis* delivery plasmid pBursa into JE2 containing the transposase-encoding plasmid pFA545, with selection on TSA medium containing chloramphenicol (Cm) (10 µg/ml) and Tet (5 µg/ml). After growth for 48 h at 30°C to allow for transposition events, one colony was resuspended in 100 µl of prewarmed 45°C water and then 10 µl was plated onto TSA plates containing erythromycin (Erm) (25 µg/ml) and grown at 45°C for 12 to 24 h. Resulting colonies, irrespective of colony size, were then screened for loss of the temperature-sensitive plasmids pBursa and pFA545 by patching them on TSA-Erm (25 µg/ml), TSA-Cm (10 µg/ml), and TSA-Tet (5 µg/ml). Those colonies that were Cm and Tet susceptible but resistant to Erm were arrayed into 1-ml deep-well plates containing 400 µl of TSB-Erm (5 µg/ml) and grown at 37°C overnight. The next day, 400 µl of 50% glycerol was added to each well and the plates were stored in a −80°C freezer.

To identify the locations of the *bursa aurealis* transposon insertions, 400 µl of TSB-Erm (5 µg/ml) was inoculated into 96-well plates using a 96-prong replicator. After overnight growth, the Wizard genomic DNA purification kit (Promega) was used to isolate genomic DNA from the cultures with the following modifications. Briefly, after centrifugation at 4,100 rpm for 5 min in a Sorvall (Newtown, CT) Legend tabletop centrifuge, supernatants were removed, the content of each well was resuspended in 110 µl of 50 mM EDTA (pH 8.0), and 5 µl of 10-mg/ml lysostaphin was added. After incubation at 37°C for 60 min, 600 µl of Nuclei Lysis solution was added and the genomic DNA was collected according to the manufacturer's instructions. After resuspension in Tris-EDTA (TE) buffer, approximately 2 µg of genomic DNA was digested with 10 units of AciI (New England Biolabs) at 37°C for 4 h. AciI was then heat inactivated at 65°C for 30 min; T4 DNA ligase (200 U) (Monserate Biotechnologies, San Diego, CA) was then added to each sample and ligated overnight at 4°C, followed by heat inactivation at 65°C for 30 min. DNA fragments spanning the *bursa aurealis* insertion sites in each sample were amplified using the Buster (5′ GCTTTTTCTAAATGTTTTTTAAGTAAATCAAGTACC 3′) and Martn-ermR (5′ AAACTGATTTTTAGTAAACAGTTGACGATATTC 3′) primer set. PCR conditions included 30 cycles with an annealing temperature of 63°C and an extension time of 3 min. Once amplified, samples of the DNA products were separated in a 1% agarose gel by electrophoresis, and the remainder was purified for sequencing using Exo-SAP-IT (GE Healthcare) according to the manufacturer's instructions. Finally, determination of the nucleotide sequences of the genomic DNA flanking the transposons was achieved using the Buster primer at the DNA Microarray and Sequencing Core Facility at the University of Nebraska Medical Center.

Phenotype screens. {#h2.3}
------------------

The NTML was screened for phenotypes on Handke mannitol medium (per liter, 10 g Bacto protease peptone, 1 g Bacto beef extract, 10 g [d]{.smallcaps}-mannitol, 5 g NaCl, 10 g Bacto yeast extract, and 2.5 mg phenol red, pH 7.4), TSA containing 1.5% nonfat dry milk as an indicator of protease activity, and TSA supplemented with 5% defibrinated rabbit blood (Becton, Dickinson, Franklin Lakes, NJ) for hemolysis activity and pigmentation changes. For the hemolysis tests, mutants were grown overnight at 37°C in deep-well 96-well plates with shaking. A 96-well solid-pin replica blotter was dipped into the cultures and then stamped onto each medium type and incubated at 37°C. Following 8 h of incubation, the plates were examined and phenotypes identified by visual inspection of zones of clearing around each colony. Any mutant with either a larger or smaller zone of clearing around the colony than that of the wild type were considered to have an altered activity. During the screen, care was taken to account for colony size differences. Likewise, protease activity and pigmentation alterations were identified by visual inspection of plates after a 24-h incubation at 37°C. The ability to ferment mannitol was viewed by a change in medium color from red to yellow around the colony. All mutants with phenotypes were arrayed into new 96-well plates with JE2 spaced intermittently as a control. These plates were then rescreened twice for observed phenotypes. Phenotypes that were observed in at least 2 out of the 3 examinations were considered valid.

SUPPLEMENTAL MATERIAL {#h3}
=====================

###### 

Relevant landmarks in the DNA sequence of the mini-*mariner bursa aurealis* transposon (Tn) region of the delivery vector pBursa. The circular pBursa plasmid is 7,383 bp long. The 3,237-bp *bursa aurealis* region is between pBursa map coordinates 7383 and 4147, which include the flanking terminal inverted repeats. (a) Region of *bursa aurealis* that becomes incorporated into the *S. aureus* USA300 LAC JE2 genome of the Nebraska Transposon Mutant Library (NTML) clones. (b) Subregion of *bursa aurealis* between the *erm*B gene's AciI site and the *erm*B Tn insertion terminus. We isolated DNA from Tn insertion clones and cleaved it with Acil. Then, genomic DNA beyond the *erm*B *bursa aurealis* terminus sequence (CCTGTTA) up to the nearest AciI site in the *S. aureus* USA300 LAC JE2 genome was isolated by circularization and amplified for DNA sequencing by inverse PCR (b and c) using the indicated reverse primer and either of the two forward primers shown (in most cases, the 42F forward primer was used). Map coordinates and DNA sequence landmarks are from the pBursa GenBank sequence (accession number AY672109.3) and are drawn to scale. The indicated strand orientation of *bursa aurealis* is shown because all mapped Tn insertion clones in the NTML are oriented with respect to transcription of the *gfp* and *erm*B genes, which are on the reverse complement strand of the pBursa GenBank sequence. Download

###### 

Figure S1, TIF file, 1.6 MB

###### 

Alignment-based determination of coordinates and orientation for mapping of Tn insertion clone DNA sequencing reads to the *S. aureus* USA300 FPR3757 genome. This genome was used for mapping because it differs from the USA300 LAC JE2 genome at only 11 nucleotide positions. Download

###### 

Figure S2, TIF file, 2.3 MB

###### 

Distribution of AciI fragment lengths in the *S. aureus* USA300 FPR3757 genome. Download

###### 

Figure S3, TIF file, 2.2 MB

###### 

Saturation of CDS genes with Nebraska Transposon Mutant Library Tn insertions in the *S. aureus* USA300 LAC JE2 genome. Download

###### 

Figure S4, TIF file, 1.7 MB

###### 

Influence of CDS gene length on Nebraska Transposon Mutant Library Tn insertion frequency. Download

###### 

Figure S5, TIF file, 2.3 MB

###### 

Identified phenotypes.

###### 

Table S1, PDF file, 143 KB.

###### 

Genes lacking Tn insertions.

###### 

Table S2, PDF file, 320 KB.

###### 

Essential gene comparisons.

###### 

Table S3, PDF file, 572 KB.
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